无菌性翻修全髋关节置换术诊断影响髋关节失能与骨关节炎结局评分临床意义阈值的差异
该前瞻性队列纳入466例2016至2022年接受无菌性翻修全髋关节置换术的患者,按诊断分层,计算HOOS疼痛、PS和JR子量表的MCID、PASS和SCB阈值。结果显示各阈值随术前诊断显著变化,无菌性松动患者改善最大且达到临床意义获益的可能性最高,假体周围骨折和不稳定患者有意义恢复率较低。
要点
- HOOS疼痛MCID从无菌性松动的10.0到假体周围骨折的12.9不等。
- HOOS-PS的PASS在假体周围骨折为76.6,在无菌性松动、假体失败和不稳定为80.0。
- 无菌性松动患者改善最大且达到临床意义获益的可能性最高,假体周围骨折和不稳定患者有意义恢复率较低。
核心结论
- 本研究建立了无菌性翻修全髋关节置换术中HOOS各子量表按诊断区分的MCID、PASS和SCB阈值,证明这些阈值随术前诊断显著变化。
- 无菌性松动患者表现出最大改善和最高达到临床意义获益的可能性,而假体周围骨折和不稳定患者有意义恢复率较低。
- 这些发现为结局评估和个体化患者咨询提供了关键框架。
研究设计与样本
- 前瞻性队列分析纳入2016年至2022年间接受无菌性翻修全髋关节置换术的466例患者。
- 患者按诊断分层:无菌性松动(n=232)、假体失败(n=112)、不稳定(n=78)和假体周围骨折(n=44)。
- 术前和1年随访时收集HOOS疼痛、HOOS身体功能简表(PS)和HOOS关节置换(JR)评分。
- MCID采用基于分布的方法计算,PASS和SCB采用基于锚定的方法确定。
主要发现
- HOOS疼痛的MCID阈值从10.0(无菌性松动)到12.9(假体周围骨折),HOOS-PS从9.9(不稳定)到12.9(假体周围骨折),HOOS-JR从8.7(无菌性松动)到12.1(假体周围骨折)。
- HOOS疼痛的PASS阈值从67.5(假体失败)到72.5(假体周围骨折),HOOS-PS从76.6(假体周围骨折)到80.0(无菌性松动、假体失败和不稳定),HOOS-JR从64.7(无菌性松动)到73.5(假体失败和不稳定)。
- HOOS疼痛的SCB阈值从15(假体失败)到35(无菌性松动),HOOS-PS从4.6(假体周围骨折)到22.0(不稳定),HOOS-JR从16.1(不稳定)到25.9(假体失败)。
关键数值与推荐
- HOOS疼痛MCID:无菌性松动10.0,假体周围骨折12.9。
- HOOS-PS的PASS:假体周围骨折76.6,无菌性松动、假体失败和不稳定均为80.0。
- HOOS-JR的SCB:不稳定16.1,假体失败25.9。
临床怎么用
- 这些按诊断区分的阈值可用于无菌性翻修全髋关节置换术后的结局评估和个体化患者咨询。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patient-reported outcome measures (PROMs) are increasingly important in assessing revision total hip arthroplasty (THA) outcomes, yet diagnosis-specific thresholds for clinical relevance remain largely undefined. This study aimed to determine diagnosis-specific minimal clinically important difference (MCID), patient-acceptable symptom state (PASS), and substantial clinical benefit (SCB) thresholds for the Hip Disability and Osteoarthritis Outcome Score (HOOS) subscales in aseptic revision THA. METHODS: A prospective cohort of 466 patients who underwent aseptic revision THA between 2016 and 2022 was analyzed. Patients were stratified by diagnosis: aseptic loosening (n = 232), implant failure (n = 112), instability (n = 78), and periprosthetic fracture (n = 44). The HOOS-pain, HOOS-physical function short form (PS), and HOOS-Joint Replacement (JR) scores were collected preoperatively and at a 1-year follow-up. The MCID was calculated using distribution-based methods, while PASS and SCB were determined using anchor-based approaches. RESULTS: The MCID thresholds ranged from 10.0 (aseptic loosening) to 12.9 (periprosthetic fracture) for HOOS-pain, 9.9 (instability) to 12.9 (periprosthetic fracture) for HOOS-PS, and 8.7 (aseptic loosening) to 12.1 (periprosthetic fracture) for HOOS-JR. The PASS thresholds varied from 67.5 (implant failure) to 72.5 (periprosthetic fracture) for HOOS-pain, 76.6 (periprosthetic fracture) to 80.0 (aseptic loosening, implant failure, and instability) for HOOS-PS, and 64.7 (aseptic loosening) to 73.5 (implant failure and instability) for HOOS-JR. The SCB thresholds spanned 15 (implant failure) to 35 (aseptic loosening) for HOOS-pain, 4.6 (periprosthetic fracture) to 22.0 (instability) for HOOS-PS, and 16.1 (instability) to 25.9 (implant failure) for HOOS-JR. CONCLUSIONS: This study established diagnosis-specific thresholds for MCID, PASS, and SCB across HOOS subscales in aseptic revision THA, demonstrating significant variability by preoperative diagnosis. Patients who have aseptic loosening showed the greatest improvement and highest likelihood of achieving clinically meaningful benefits, while those who have periprosthetic fractures and instability had lower rates of meaningful recovery. These findings provide a critical framework for outcome assessment and personalized patient counseling.
引用
- Pasqualini I, Benyamini B, Khan ST, et al. Measures of Clinical Meaningfulness for the Hip Disability and Osteoarthritis Outcome Score Vary by Aseptic Revision Total Hip Arthroplasty Diagnosis. J Arthroplasty. 2025. PMID: 40339942. doi:10.1016/j.arth.2025.04.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。